Zynex Inc (ZYXI) 0.1479 $ZYXI
Zynex's (ZYXI) CEO Thomas Sandgaard on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 02, 12:29PM CDT
Zynex Announces 2014 Year End Results
Marketwired - Thu Apr 02, 7:01AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today 2014 year-end financial results.
Zynex Receives 43rd Pharmacy License Approval
PRWeb - Mon Mar 30, 8:09AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it has received license approval from the State of Oregon for its compound pharmacy business Pharmazy. This brings to 43 the total states, including the District of Columbia, in which the Company is licensed to provide compound pharmacy services.
Zynex Schedules 2014 Year End Earnings Conference Call and Webcast
Marketwired - Thu Mar 26, 7:00AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it will host an investor webcast on Thursday, April 2, 2015 at 11:00 a.m. ET (9:00 a.m. MT) to discuss the Company's 2014 year-end results.
Zynex wins its 42nd pharmacy licence in Kentucky
M2 - Thu Mar 19, 6:51AM CDT
Medical technology company Zynex (OtherOTC:ZYXI) reported on Wednesday the receipt of licence approval for its compound pharmacy business Pharmazy in the State of Kentucky.
Zynex, Inc. Hires Two Key Managers for Compliance and Quality
GlobeNewswire - Fri Feb 13, 4:06AM CST
via PRWEB - Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the recent hire of Colin Glennan, CHC as Director of Compliance and Todd Romero as Director of Quality.
Zynex Provides Operations Update
Marketwired - Mon Jan 05, 12:43PM CST
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the following operational updates for shareholders:
Zynex Achieves Compound Pharmacy License Approval in 40th State
Marketwired - Thu Nov 20, 7:57AM CST
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pain creams, announced today that it attained compound pharmacy licensing approval in the state of Iowa, marking its fortieth state approval.
Zynex beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:04AM CST
Zynex Announces Third Quarter 2014 Results
Marketwired - Fri Nov 07, 7:01AM CST
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pain creams, announced today its unaudited financial results for the three and nine months ended September 30, 2014.
Zynex reports November 7
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 8:04AM CST
Zynex Schedules Third Quarter 2014 Earnings Release and Webcast
Marketwired - Fri Oct 31, 3:17PM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it will host the Company's third quarter investor webcast on Friday, November 7 at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time.
Zynex Hires Michael Frabotta as VP of Sales
Marketwired - Thu Oct 16, 7:03AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the recent hire of Michael Frabotta as Vice President of Sales. Mr. Frabotta is responsible for Zynex Medical's sales organization, promoting electrotherapy and compound pharmacy products throughout the United States.
Zynex Announces Second Quarter 2014 Results
Marketwire - Thu Sep 25, 7:01AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today its unaudited financial results for the three and six months ended June 30, 2014.
Zynex Reschedules Second Quarter 2014 Earnings Release and Webcast to September 25, 2014
Marketwire - Wed Sep 17, 5:34PM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the date for the Company's second quarter investor webcast has been rescheduled to Thursday, September 25th at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time.
Zynex's (ZYXI) CEO Thomas Sandgaard on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 02, 12:29PM CDT
Zynex Announces 2014 Year End Results
Marketwired - Thu Apr 02, 7:01AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today 2014 year-end financial results.
Zynex Receives 43rd Pharmacy License Approval
PRWeb - Mon Mar 30, 8:09AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it has received license approval from the State of Oregon for its compound pharmacy business Pharmazy. This brings to 43 the total states, including the District of Columbia, in which the Company is licensed to provide compound pharmacy services.
Zynex Schedules 2014 Year End Earnings Conference Call and Webcast
Marketwired - Thu Mar 26, 7:00AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it will host an investor webcast on Thursday, April 2, 2015 at 11:00 a.m. ET (9:00 a.m. MT) to discuss the Company's 2014 year-end results.
Zynex wins its 42nd pharmacy licence in Kentucky
M2 - Thu Mar 19, 6:51AM CDT
Medical technology company Zynex (OtherOTC:ZYXI) reported on Wednesday the receipt of licence approval for its compound pharmacy business Pharmazy in the State of Kentucky.
Zynex, Inc. Hires Two Key Managers for Compliance and Quality
GlobeNewswire - Fri Feb 13, 4:06AM CST
via PRWEB - Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the recent hire of Colin Glennan, CHC as Director of Compliance and Todd Romero as Director of Quality.
Zynex Provides Operations Update
Marketwired - Mon Jan 05, 12:43PM CST
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the following operational updates for shareholders:
Zynex Achieves Compound Pharmacy License Approval in 40th State
Marketwired - Thu Nov 20, 7:57AM CST
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pain creams, announced today that it attained compound pharmacy licensing approval in the state of Iowa, marking its fortieth state approval.
Zynex beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:04AM CST
Zynex Announces Third Quarter 2014 Results
Marketwired - Fri Nov 07, 7:01AM CST
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pain creams, announced today its unaudited financial results for the three and nine months ended September 30, 2014.
Zynex reports November 7
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 8:04AM CST
Zynex Schedules Third Quarter 2014 Earnings Release and Webcast
Marketwired - Fri Oct 31, 3:17PM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today that it will host the Company's third quarter investor webcast on Friday, November 7 at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time.
Zynex Hires Michael Frabotta as VP of Sales
Marketwired - Thu Oct 16, 7:03AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the recent hire of Michael Frabotta as Vice President of Sales. Mr. Frabotta is responsible for Zynex Medical's sales organization, promoting electrotherapy and compound pharmacy products throughout the United States.
Zynex Announces Second Quarter 2014 Results
Marketwire - Thu Sep 25, 7:01AM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today its unaudited financial results for the three and six months ended June 30, 2014.
Zynex Reschedules Second Quarter 2014 Earnings Release and Webcast to September 25, 2014
Marketwire - Wed Sep 17, 5:34PM CDT
Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurological diagnostics, and compound pharmacy, announced today the date for the Company's second quarter investor webcast has been rescheduled to Thursday, September 25th at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time.
